IJ Psychiatry and Behavioral Sciences
IJPBS is the Official Journal of Mazandaran University of Medical Sciences
CrossRef
Works that cite this article, indexed by Crossref.
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis
Drug and Alcohol Dependence 219 (2021)
Manit Srisurapanont; Surinporn Likhitsathian; Sirijit Suttajit; Narong Maneeton; Benchalak Maneeton; Awirut Oon‐arom; Chawisa Suradom
Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study
Psychopharmacology Bulletin 49(1) (2025)
Raul Felipe Palma-Álvarez; Elena Ros-Cucurull; Josep Antoni Ramos-Quiroga; Carlos Roncero; Lara Grau-López
Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801
Pharmacology Biochemistry and Behavior 175 (2018)
Peter U. Hámor; Jana Šírová; Tomáš Páleníček; Magdalena Zaniewska; Věra Bubeníková-Valešová; Marek Schwendt
Commentary on the ANZJP Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia – Where are the recommendations for methamphetamine-related psychoses?
Australian & New Zealand Journal of Psychiatry (2026)
Cherrie Galletly; Shalini Arunogiri; Edward Hall; Stephen Parker; Grant Sara; Julia Lappin
Methamphetamine Dependence and Technology-Based Interventions in Iran
Iranian Journal of Psychiatry and Behavioral Sciences 12(2) (2018)
Mohammad Effatpanah; Afsaneh Moradi
Initiation of Antipsychotic Treatment for Amphetamine Induced Psychosis and Its Impact on Length of Stay
Journal of Pharmacy Practice 36(6) (2023)
Claire Herbst; Megan O’Connell; Brittany L. Melton; Karen E. Moeller
Optimal drug, dose and duration of antipsychotic therapy following amphetamine and cannabis-induced psychosis: A systematic review
Australian & New Zealand Journal of Psychiatry (2026)
Edward Hall; Nisitha Ratnayake; Jana Waldmann; Mark Daglish; James G. Scott; Jason P. Connor; Stephen Parker
Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern
DARU Journal of Pharmaceutical Sciences 27(2) (2019)
Mansour Khoramizadeh; Mohammad Effatpanah; Alireza Mostaghimi; Mehdi Rezaei; Alireza Mahjoub; Sara Shishehgar
Methamphetamine‐associated psychosis: Clinical presentation, biological basis, and treatment options
Human Psychopharmacology: Clinical and Experimental 34(5) (2019)
Mathew Chiang; Domenico Lombardi; Jiang Du; Ursula Makrum; Rangsun Sitthichai; Amy Harrington; Nawras Shukair; Min Zhao; Xiaoduo Fan
Antipsychotics for Amphetamine Psychosis. A Systematic Review
Frontiers in Psychiatry 10 (2019)
Dimy Fluyau; Paroma Mitra; Kervens Lorthe
Into a Deeper Understanding of CYP2D6’s Role in Risperidone Monotherapy and the Potential Side Effects in Schizophrenia Spectrum Disorders
International Journal of Molecular Sciences 25(12) (2024)
Mariana Bondrescu; Liana Dehelean; Simona Farcas; Patricia Alexandra Dragan; Carla Andreea Podaru; Laura Popa; Nicoleta Andreescu